The clinical importance of P. carinii as an opportunistic pulmonary pathogen is well established, but research progress on the organism has generally been slow. In recent years, the application of molecular biology techniques to P. carinii has substantially altered our concepts of the organism's taxonomy. Advances are also being made in our understanding of the immunology and pathogenesis of this infection. Continued success in these areas should ultimately lead to novel approaches to therapy.
|Original language||English (US)|
|Number of pages||16|
|Journal||Bailliere's Clinical Infectious Diseases|
|State||Published - Dec 8 1995|
ASJC Scopus subject areas
- Microbiology (medical)